Attached files

file filename
EX-10.1 - EX-10.1 - AVROBIO, Inc.avro-ex101_30.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 4, 2020

AVROBIO, INC.
(Exact name of registrant as specified in its charter)

Delaware

001-38537

81-0710585

(State or other jurisdiction
of incorporation)

(Commission
File Number)

(I.R.S. Employer
Identification No.)

 

One Kendall Square
Building 300, Suite 201
Cambridge, MA 02139
(Address of principal executive offices, including zip code)

(617) 914-8420
(Registrant’s telephone number, including area code)

Not Applicable
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading

symbol(s)

  

Name of each exchange

on which registered

Common Stock, $0.0001 par value per share

  

AVRO

  

Nasdaq Global Select Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


Item 5.07 Submission of Matters to a Vote of Security Holders.

On June 4, 2020, AVROBIO, Inc. (the “Company”) held its previously announced 2020 Annual Meeting of Stockholders (the “Meeting”), at which a quorum was present. The proposals voted on at the Meeting and the final voting results for each proposal are as follows:

1. The Company’s stockholders elected the two director nominees listed below to serve as Class II directors until the Company’s 2023 annual meeting of stockholders, with the votes cast as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

Director Nominee

  

Votes For

 

  

Votes Withheld

 

  

Broker Non-Votes

 

Ian Clark

  

 

19,402,202

 

  

 

11,160,529

 

  

 

4,076,826

 

Annalisa Jenkins, M.B.B.S., F.R.C.P.

  

 

25,186,686

 

  

 

5,376,045

 

  

 

4,076,826

 

 

2. The Company’s stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2020, with the votes cast as follows:

Votes For

 

Votes Against

 

Abstentions

 

Broker Non-Votes

34,618,405

 

19,412

 

1,740

 

 

3. The Company’s stockholders approved an amendment to the AVROBIO, Inc. 2018 Stock Option and Incentive Plan, with the votes cast as follows:

Votes For

 

Votes Against

 

Abstentions

 

Broker Non-Votes

24,179,440

 

6,377,237

 

6,054

 

4,076,826

 

 

Item 9.01.

Financial Statements and Exhibits.

(d) Exhibits

 

 

 

 

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

AVROBIO, INC.

Date: June 9, 2020

By:

/s/ Geoff MacKay

 

 

 

 

Geoff MacKay

 

 

 

President and Chief Executive Officer